Special Issue "Hybrid Multifunctional Drug Delivery Systems"
Deadline for manuscript submissions: 31 August 2020.
Interests: enabling formulations; nanoparticles; microencapsulation technologies; nanomedicine, additive manufacturing; oral drug delivery; particle engineering; lipid-based formulations
Interests: nanomedicine; drug delivery; biomaterials engineering; bioimaging probes; biomedical nanotechnology; pharmaceutical technology
Special Issues and Collections in MDPI journals
Special Issue in Micromachines: Nanostructures for Bioimaging
Special Issue in Molecules: Mesoporous Silica in Biomedical Applications 2020
Interests: oral drug delivery; delivery systems; microfabrication; nano- and microparticles; drug formulations; additive manufacturing; pharmaceutical technology
Remarkable developments have been made in the field of particulate-based drug delivery systems to overcome hurdles associated with conventional drug formulations for diagnostic and therapeutic applications. The vast array of today’s nano- and microparticle platforms include polymeric nanoparticles, lipid carrier systems (i.e., liposomes, solid lipid nanoparticles, and nanostructured lipid carriers) as well as different types of inorganic particles (i.e., quantum dots, mesoporous materials, and metal oxides). Hybrid drug carriers combine structural components from two or more (typically organic and inorganic) materials and are the next frontier in the development of novel, multifunctional drug delivery systems, as they benefit from the synergistic properties of the individual components. Typical examples include functionalization of inorganic particles with organic constructs combining structural robustness with functional responsiveness. This course of action is usually taken in order to enhance drug encapsulation efficiency and to control drug release, or for the design of theranostic nanomaterials for simultaneous imaging and therapy.
The aim of this Special Issue is to highlight recent advances in all aspects relevant to hybrid multifunctional drug delivery systems, with a focus on particle-based systems, ranging from synthesis methods and process understanding, their detailed physicochemical characterization and performance in vitro and in vivo, especially for controlled and/or targeted drug delivery applications.
Assist. Prof. Alexandra Teleki
Prof. Jessica Rosenholm
Assoc. Prof. Line Hagner Nielsen
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- drug delivery
- hybrid materials
- targeted delivery